News Laboratorio Farmaceutico Erfo S.p.A.

Stocks

ERFO

IT0005497885

Pharmaceuticals

Market Closed - Borsa Italiana 11:45:00 2026-08-21 am EDT			5-day change	1st Jan Change
1.125 ^EUR	0.00%		-1.32%	-23.47%

Jul. 06	Laboratorio Erfo continues buyback, acquires 15,000 treasury shares	AN
Jun. 29	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN

All News

Mentions Relevance

Jul. 06	Laboratorio Erfo continues buyback, acquires 15,000 treasury shares	AN
Jun. 29	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN
Jun. 22	Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares	AN
Jun. 19	Laboratorio Farmaceutico Erfo S.p.A.'s Equity Buyback announced on December 18, 2024, has expired.	CI
Jun. 15	Laboratorio Farmaceutico Erfo acquires 15,000 treasury shares	AN
May. 21	Laboratorio Farmaceutico Erfo reports stable first-quarter revenue year-on-year	AN
May. 21	Laboratorio Farmaceutico Erfo Q1 EBITDA adj. EUR 0.5 mln	RE
Apr. 12	Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Apr. 09	Laboratorio Farmaceutico Erfo S p A : Investor Presentation Erfo SpA FY2025 (ENG)	PU
Mar. 30	Laboratorio Farmaceutico Erfo posts triple-digit profit growth in 2025	AN
Feb. 19	Erfo Increases EBITDA in 2025; Revenues More Than Double	AN
Feb. 19	Laboratorio Farmaceutico Erfo FY EBITDA EUR 2.0 Mln	RE
Nov. 21	Erfo Pharmaceutical Laboratory, revenues grow by 57% in nine months	AN
Nov. 21	Laboratorio Farmaceutico Erfo 9m Ebitda EUR 1.7 mln	RE
25-10-21	Laboratorio Farmaceutico Erfo S p A : 2025 10 20-ERFO-NextGEMS	PU
25-09-29	Erfo Pharmaceutical Laboratory improves profits in the first half	AN
25-09-29	Erfo H1 EBITDA EUR 1.2 mln	RE
25-09-26	Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-29	Laboratorio Farmaceutico Erfo S p A : 2025 08 28 ERFO - Press release KPI 1H 2025	PU
25-08-28	Laboratorio Erfo Reports Double-Digit Growth in Revenue and EBITDA for First Half	AN
25-08-28	Laboratorio Farmaceutico Erfo H1 ebitda eur 1.2 mln	RE
25-07-14	Laboratorio Farmaceutico Erfo Purchases 13,000 Own Ordinary Shares	AN
25-06-23	Erfo Closes Warrant Exercise Period Without Conversions	AN
25-06-04	Laboratorio Farmaceutico Erfo S p A : KT Erfo 1Q25 Final	PU
25-05-23	Laboratorio Erfo, revenues and EBITDA up significantly in the quarter	AN